Makar Ralph 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jun 27, 2008
Insider Transaction Report
Form 4
Makar Ralph
CEO/President
Transactions
- Award
BJCT Common Stock
2008-06-25+197,368→ 197,368 total
Holdings
- 474,267
Restricted Stock Unit
Exercise: $0.00→ BJCT Common Stock (150,000 underlying)
Footnotes (3)
- [F1]The Stock Grant was in lieu of $75,000 cash award that was earned by Mr. Makar pursuant to his employment agreement related to 2007 performance.
- [F2]Restricted Stock Unit vest in 3 equal annual installments beginning 12/31/08 pursuant to Executive Employement Agreement.
- [F3]Includes Series F Preferred Stock 67,600, Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000. Restricted Stock Unit 250,000.